For the past few years, nanotechnology has provided a lot of new treatment opportunities for
prostate cancer patients, and brilliant achievements have been acquired indeed. It not only …

Prostate cancer (PCa) is one of the leading cancers in men and the lack of suitable
biomarkers or their modulators results in poor prognosis. Membrane proteins (MPs) have a …

The present work describes the engineering of anti-PSMA peptide-decorated exosome
mimetics (EMs) targeting advanced prostate cancer (PC). The targeted EMs were produced …

Prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II
(GCPII), is a suitable target for specific delivery of antitumor drugs and diagnostic agents due …

Prostate cancer is one of the most commonly diagnosed men's cancers and remains one of
the leading causes of cancer death. The development of approaches to the treatment of this …

Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of
advanced prostate cancer (PC) and various solid tumors. Although PSMA-targeted …

Prostate-specific membrane antigen (PSMA) has been identified as a target for the
development of theranostic agents. In our current work, we describe the design and …

Purpose Most chemotherapeutic agents possess poor water solubility and show more
significant accumulations in normal tissues than in tumor tissues, resulting in serious side …

A strategy for stereoselective synthesis of molecular platform for targeted delivery of bimodal
therapeutic or theranostic agents to the prostate-specific membrane antigen (PSMA) …

To evaluate the chemotherapeutic efficacy of J591 fabricated poly (d, l)-lactic-co-glycolic
acid (PLGA) nanoparticles containing paclitaxel (Ab-PTX-NP) in vitro in PSMA (prostate …